VivoSim Labs, Inc. (VIVS)
Last updated: 2026-10-24 17:25:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
VivoSim Labs, Inc. (VIVS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.15, with a market capitalization of $2.13M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.14 to $3.40. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$2.13M | |
$0.15 | |
$5.30 | |
$0.14 | |
$0.16 | |
743.14K | |
2.87M | |
-- | |
$3.40 | |
$0.14 | |
-- | |
-- |
VivoSim Labs, Inc. (VIVS) Latest Closing Stock Price
VivoSim Labs, Inc. (VIVS) last closed at $0.16 as of 2026-10-23 23:33:00, unchanged from the previous close of $0.16.
During the latest regular trading session, VIVS traded between $0.14 and $5.30, with a volume of 743.14K shares. The closing price was near the lower end and near the lower end of its 52-week range.
VivoSim Labs, Inc. (VIVS) 7-Day Stock Price Change
Over the past seven days, VivoSim Labs, Inc. (VIVS) moved from $0.17 to $0.15, representing a decline of 13.45% ($0.02).
The stock traded between $0.14 and $0.19 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.64 million shares, up versus the previous seven-day period, indicating higher trading activity.
VIVS 52-Week Price Position
Position in Range: 0.1%
VIVS is currently trading at $0.15, placing it 0.1% of the way from its 52-week low of $0.14 to its 52-week high of $3.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is VivoSim Labs, Inc. (VIVS)?
VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.
VivoSim Labs, Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
How to Buy VivoSim Labs, Inc. (VIVS) Stock on MEXC
Eligible investors can buy real shares of VivoSim Labs, Inc. (VIVS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is VivoSim Labs, Inc. (VIVS) stock price today?
2.Is VIVS stock going up or down today?
3.What is VIVS pre-market price?
4.What is VIVS after-hours price?
5.Is VIVS stock trading now?
6.Where does VIVS sit relative to its 52-week high and low?
7.What sector is VivoSim Labs, Inc. in?
8.What is VivoSim Labs, Inc.'s market capitalization and where is it listed?
9.How is VIVS valued in terms of P/E ratio and EPS?
10.Does VivoSim Labs, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
VIVS Stock Calculator
Estimate the value between VIVS shares and USD.
VIVS Shares to USD
1.00 VIVS shares = 0.148 USD
Calculations are estimates based on the latest available price and are for reference only.


